T.J. Dengler

Polymeric Nanoparticles for Drug Delivery

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients

Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation

Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil inde novocardiac transplant recipients: a randomized, multicenter study